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Running Head: An objective measure provides faster ADHD diagnosis
2Abstract
Background: Diagnosing attention deficit/hyperactivity disorder (ADHD) in children and
young-people typically relies on clinical observation and subjective parent, teacher and self-
reports. The subjective nature of reports combined with contradictory or missing data can
result in diagnostic uncertainty and delay. The aim of this study was to assess whether the
addition of an objective test of attention, impulsivity and activity (QbTest) as an adjunct to
standard ADHD assessment could accelerate the diagnostic process in routine National
Health Service (NHS) settings. Method: In a pre- vs. post-test audit design, case records
were examined in 40-cases diagnosed without the QbTest [pre-QbTest group] and 40-cases
diagnosed with the QbTest [QbTest group], recording the number of consultations until a
confirmed ADHD diagnosis was reached. Results: Using Poisson regression, significantly
fewer clinician consultations (mean 2.18 vs. 3.05; p<0.02) were required to confirm the
diagnosis of ADHD when the QbTest was used to augment assessment in comparison to
standard assessment as usual. Conclusions: The findings suggest that the addition of the
QbTest to standard clinical assessment may reduce time to diagnosis and potentially result in
cost savings to the NHS. These preliminary data suggest that there is a potentially clinically
meaningful benefit of adding the QbTest to routine clinical ADHD assessment and this
should be should be examined next in the context of a randomised controlled trial.
Key words: QbTest, audit, attention deficit/hyperactivity disorder (ADHD), diagnosing,
assessment
3Key Practitioner Messages
 ADHD assessment can be lengthy and heavily reliant on clinical interpretation of
subjective reports from parents, teachers and young people.
 This audit found adding the QbTest to standard clinical assessment of ADHD
significantly reduces the number of clinician consultations required to confirm a
diagnosis.
 First data to suggest that the QbTest may facilitate standard ADHD assessment,
resulting in rapid ADHD diagnosis, particularly in cases of missing or conflicting
rating scales.
 Future research is required to establish the utility of the QbTest to reduce time to
accurate diagnosis and further investigate the effect of this on patient outcome and
costs to the NHS.
4Introduction
The assessment of attention deficit/hyperactivity disorder (ADHD) in children
typically relies on the clinician’s judgement and the integration of various forms of subjective
information, such as parent, teacher and the young person’s report. This process is heavily
reliant on subjective interpretation and can be hindered when reports are not completed, or
contain contradictory evidence. The assessment of ADHD is further complicated by a high
co-occurrence with other disorders, making a differential diagnosis difficult, increasing the
number of clinic visits and resulting in substantial expenditure for the National Health
Service (NHS) (King et al., 2006).
Adding objective measures of ADHD may help facilitate the diagnostic process.
Continuous performance tests (CPT) are neuropsychological tests that typically involve the
rapid presentation of visual or auditory stimuli. Participants are requested to respond to a
target stimulus but not respond to non-targets. In doing so, the CPT measures the
participant’s ability to sustain attention and inhibit responses (impulsivity). There are several
well validated CPTs (Forbes, 1998; Sandford & Turner, 2002; Conners, 2000) and previous
research has demonstrated that children with ADHD perform worse on these tasks then
children without ADHD (Loiser, McGrath, & Klein, 1996). However, a limitation of the
traditional CPT is it does not measure the patient’s activity level; a core symptom of ADHD.
The QbTest (Qbtech Ltd) is one neuropsychological test that has been designed to
measure the three core symptom domains of ADHD: attention, impulsivity and activity. The
QbTest combines a computerised CPT with an infra-red motion capture of head movement to
measure activity during the task. The QbTest requires participants to respond to an
infrequently presented stimulus (by pressing a button), but ignore all other stimuli. QbTest
provides information on each of the three symptom domains of ADHD and provides a
5summary report based on deviation from a normative age and gender data set. The QbTest
has been approved by the US Food and Drug Administration (ref: K13382) and although it is
not a stand-alone diagnostic tool, several UK NHS ADHD clinics have incorporated the
assessment as an adjunct to standard clinical practice. QbTest is easy to administer, with
simple participant instructions. Research has demonstrated the QbTest can differentiate
ADHD children from normative controls (Oades et al., 2010), with sensitivity and specificity
of around 90% (Ulberstad, 2012, Unpublished data). Other research suggests the addition of
the QbTest to ADHD assessment can improve clinical decision making. For example, Vogt
and Shameli (2011) found that children who were diagnosed with the addition of the QbTest
to standard assessment practice were less likely to receive a changed diagnosis one-year later,
than those diagnosed without the addition of the QbTest.
A clinically important question is whether using QbTest reduces the overall time and
number of clinic visits required to make correct ADHD diagnosis. Despite the adoption of
QbTest in several clinics, to date no research has investigated this possibility. The aim of this
audit was to assess whether the addition of the QbTest to standard clinical assessment
reduced number of visits to reach a diagnosis in routine NHS settings.
Method
A total of 80 patient records were retrospectively examined in a community paediatric
ADHD clinic in Medway NHS Foundation Trust. Case-notes were accessed by a member of
the Trust’s clinical team (KS). The Trust introduced QbTest in July 2012. The baseline audit
was conducted on 40 new cases referred to the clinic prior to the introduction of QbTest
between June and December 2011 (pre-QbTest group). This time period was selected to
reflect the most current practice up to the introduction of the QbTest, but prior to clinicians’
having any practice using QbTest. The re-audit was conducted on 40 new cases referred
6between August 2012 and April 2013 (QbTest group), to reflect clinical practice directly after
installation of the QbTest (QbTest group). The time period for both groups was selected to
allow 40 cases to have been diagnosed. During this time period there was no change to the
assessment process, except the QbTest. Methods of acquiring parent and teacher information,
and the quantity and quality of information, remained unchanged, as did members of the
clinical and administration team. All clinicians were experienced in ADHD assessment, with
at least 4 years of clinical practice at the time of the first audit.
Inclusion Criteria
Patient files were selected using a random-number generator (Schulz & Grimes,
2002). Case notes were included if the case had received a primary diagnosis of ADHD
within the time frame specified. For the re-audit, cases were also only included if they had
received a QbTest as part of their diagnostic assessment. No cases in the baseline audit had
undergone a QbTest. If a file was excluded the next eligible file along was used. All
diagnoses were made according to the ICD-10 criteria for Hyperkinetic Disorder (F90) which
broadly equivalent to severe combined sub-type ADHD in DSM-IV and DSM-5. A
standardised audit tool was used to record the diagnosis and number of clinician consultations
that each child had before the diagnosis of ADHD was confirmed.
Forty case notes were included for both the baseline and re-audit, resulting in a total
of 80 records. Standard assessment within the Trust involves sending out the Strength &
Difficulties Questionnaire (SDQ; Goodman, 1997) to parents and teachers alongside a school
information form. At first consultation the child’s developmental history is taken, the
Conners’ parent and teacher rating scales (Conners et al., 1998a,b) are sent out and the SDQ
and school information form is reviewed by the clinician. For each group, additional
7consultations were made as necessary to make a diagnosis. For cases diagnosed in the QbTest
group, the QbTest was conducted by a nurse prior to the patient’s clinical consultation.
Clinicians were provided with the QbTest result at the second appointment. Qbtech provide
training to all clinicians upon installation of the QbTest, this includes multiple practice tests,
discussions, and demonstrations. Qbtech clinical advisors ensure that every clinician has
reached a good standard of test interpretation before they are considered competent to
interpret test results alone. Additionally, clinical advisors are always available to offer
additional test interpretation support when required. It is stressed that the QbTest is not
considered a standalone ADHD assessment and should be used to compliment rating scales
and clinical interviews and interpreted within the clinical context by qualified healthcare
professionals only.
Given this was a clinical audit conducted by staff within the Trust for purposes of
service evaluation, ethical approval was not required.
Analysis
A Poisson regression was conducted to compare the mean number of clinician
consultations needed to reach a diagnosis between the Pre-QbTest (baseline audit) and
QbTest (re-audit) group. Incidence rate ratio was reported as measure of group difference
with a 95% Confidence Interval. STATA 13 was used to conduct descriptive statistics and
Poisson regression modelling.
Results
The pre-QbTest group consisted of 32 boys (80%) and 8 girls (20%), with a mean age
of 8.1years (SD= 2.4 years range: 4.5 – 14.6 years), the QbTest group consisted of 28 boys
(70%) and 12 girls (30%), with a mean age of 9.2years (SD = 2.3 years, range: 6.2 – 13.10
8years). All children had received a primary diagnosis of ADHD (ICD-10, F90). Children in
the QbTest group were slightly older than those in the pre-QbTest group (t(39) = -2.23, p =
.03), there was no difference in gender between the two groups (χ² = .730, p = .55). In the
pre-QbTest group 15 children also received a secondary diagnosis: 6 children received a
secondary diagnosis of autism spectrum disorder (ASD), 2 ASD and tic disorder, 2 ASD and
dyspraxia, 1 ASD and obsessive compulsive disorder, 1 oppositional defiance disorder, 1
sensorineural deafness, 1 mild epilepsy, 1 Tourette’s syndrome. In the QbTest group 13
children received a secondary diagnosis: 7 children received a secondary diagnosis of ASD, 1
Tourette’s syndrome, 1 sensory processing disorder, 1 mild speech and language disorder, 1
emotional difficulties, 1 dyslexia and 1 learning difficulties.
Table 1 shows the number of clinician consultations needed to reach an ADHD
diagnosis for both groups. For both groups, most diagnoses were made at the 2nd consultation.
However, for the pre-QbTest group 55% (22 patients) required more than 2 consultations, in
the QbTest group only 18% (9 patients) required 2 or more consultations to confirm an
ADHD diagnosis, and all diagnoses were made by the 4th consultation.
[INSERT TABLE 1 HERE]
Poisson regression (Table 2) showed the children in the QbTest group needed
significantly fewer clinician consultations to reach a diagnosis (average 2 consultations) than
children in the pre-QbTest group (average 3 consultations).
[INSERT TABLE 2 HERE]
The cost of a consultation within the Trust at the time of audit equated to £108.00. A
single QbTest cost the Trust £31.00 (including the cost of the test as a proportion of the lease
fee, and a 30 minutes Nurse-led appointment to conduct the test). As such, the total cost spent
9on ADHD assessment in the pre-QbTest group equated to £13,176, compared to £10,636 in
the QbTest group, equating to saving of £2,540. It should also be noted that as the QbTest
equipment is leased to clinics, there is no additional start-up cost.
In cases where five or more clinician consultations were required to make a diagnosis,
the responsible clinicians were asked the reasons behind the delay in diagnosis. For 4/6
(66.6%) of cases, inconclusive or discrepancy outcomes from clinical rating scales were cited
as the primary reason for delay, one case (17.0%) cited complex co-morbidities, and one
(17.0%) clinician reluctance to make a diagnosis. We chose only to seek clarification from
clinicians with five or more consultations to make diagnosis as given the often complex
nature of ADHD it would not be atypical to require a few consultations to confirm a
diagnosis (see Table 1). Clinicians were asked how the QbTest helped aid diagnosis,
responses included: the ability to compare the child’s performance against a normed data set,
the opportunity to directly observe the child’s behaviour whilst performing a task, and the
provision of an objective, graphical report to compare to subjective reports.
Discussion
To assess whether the QbTest decreased number of clinic visits needed to reach an
ADHD diagnosis we compared the number of clinician consultations required to reach a
diagnosis in randomly selected cases who were diagnosed with (QbTest group) and without
(pre-QbTest group) the QbTest. Our findings reveal a significant reduction in the number of
clinician consultations, from 3 to 2 consultations on average, required to confirm a diagnosis
when the standard assessment procedure was supplemented with a QbTest. Based on these
audit findings it would be unwise to draw definitive conclusions, however, these preliminary
data suggest that the QbTest may facilitate standard ADHD assessment and result in more
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rapid ADHD diagnosis in children, particularly in cases of missing or conflicting rating
scales. The time and cost savings described here are likely to be clinically important if
confirmed by a randomised controlled trial. In turn, rapid accurate assessment could
facilitate appropriate treatment onset and improve patient outcomes. It could be argued that
the pre-QbTest was a more complex client group, with a slightly higher co-morbidity of ASD
(10%). However, the 10% difference in ASD is unlikely to explain the significant increase in
the number of patients diagnosed by the 2nd appointments in the QbTest group (from 18%
pre-QbTest to 55% after the introduction of QbTest).
These findings support and extend previous research demonstrating the utility of the
QbTest to aid ADHD assessment in children. Previous research has indicated that QbTest can
differentiate ADHD from healthy controls (Oades et al., 2012; Ulberstad, 2012, unpublished
data), and result in improved clinical decision making (Vogt & Shameli, 2011). This current
study is the first to show this improved decision making may result in a reduction of clinical
consultations and cost saving to NHS practice.
A limitation of the study was that the ADHD diagnoses were not independently
verified and it is not known if QbTest also facilitated the exclusion of an ADHD diagnosis in
non-ADHD cases referred for ADHD diagnostic assessment, limiting the comprehensiveness
of these findings. Our findings are limited to the practice of one NHS Trust and a relatively
small sample size, and our conclusions should be interpreted within these methodological
constraints. Despite this, these findings represent the first insight into the potential of the
QbTest to streamline clinical practice and produce a clinically important time and cost saving
to the NHS. This result should be used to inform a future randomised controlled trial
comprising a full economic analysis (Hall et al., 2014). Strengths to this audit include the
similar composition of children in each group and the random selection of cases. We stress
the need for further randomised studies in a larger number of clinical settings to establish
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whether the QbTest does facilitate both accurate and speedy diagnosis of ADHD and
exclusion of ADHD in non-ADHD cases in routine NHS clinics (Hall et al., 2014).
Conclusion
The implementation of QbTest as an adjunct to standard clinical assessment of ADHD
in children reduced the number of clinician consultations required to reach an ADHD
diagnosis. The clinical utility of the QbTest to streamline and improve ADHD practice is
worthy of more rigorous clinical trials.
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Tables
Table 1 Number of clinician consultations until a diagnosis was reached in the pre-QbTest
and QbTest group
Number of children in which an ADHD diagnosis was made at respective
consultation
1st
consult
(%)
2nd
consult
(%)
3rd
consult
(%)
4th
consult
(%)
5th
consult
(%)
6th
consult
(%)
7th
consult
(%)
Pre-QbTest
group
4 (10.0) 14 (35.0) 7 (17.5) 9 (22.5) 4 (2.9) 1.0 (2.5) 1 (2.5)
QbTest
group
4 (10.0) 27 (67.5) 7 (17.5) 2 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)
Note. consult = consultation. Percentages are reported in parentheses.
Table 2 Poisson regression comparison of number of clinician consultations until diagnosis
Mean (min, max
consultation)
Total number of
consultations to make
40 diagnoses
Poisson Regression
IRR (95%CI)
Pre-QbTest group 3.05 (1, 7) 122
0.71 (0.54, 0.94), p = .02QbTest group 2.18 (1, 4) 97
Note. CI = Confidence Interval.
